Humanigen Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and thanks for joining us at the JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst. Our next presenting company this morning is Humanigen, and it's my pleasure to welcome and introduce CEO, Cameron Durrant, to tell us a little bit about the company.
Before I hand it over for the presentation, I just want to remind folks that there is a Q&A after the presentation. Feel free to submit a question by clicking the icon just to the right of the screen.
With that, Cameron, thanks for sharing some of your time with us this morning.
Of course. Thank you, Eric. Great to see you again. Well, welcome, everyone, and thank you for attending the Humanigen presentation.
The focus of this 20-minute-or-so presentation will be our COVID Phase III progress and our commercial plan in the context of the rapidly changing treatment vaccination and competitive landscape.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |